Lifshitz Law PLLC Announces Investigations of United Homes Group, Inc. (NASDAQ: UHG), Upstart Holdings, Inc. (NASDAQ: UPST), Medpace Holdings, Inc. (NASDAQ: MEDP), and Gossamer Bio, Inc. (NASDAQ: GOSS)

NEW YORK CITY, NY / ACCESS Newswire / August 25, 2026 / Lifshitz Law Firm

United Homes Group, Inc. (NASDAQ:UHG)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) United Homes' controlling shareholder, Michael Nieri, intended to force a sale of the Company; (ii) Nieri was taking actions to devalue the Company and its financial condition; (iii) Nieri leveraged his controlling interest to effectuate that sale, including by effectively forcing the dissident directors to resign; and (iv) as a result of the foregoing, Nieri was not acting in the best interests of United Homes and public investors.

If you are a UHG investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Upstart Holdings, Inc. (NASDAQ:UPST)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) Model 22 frequently overreacted to negative macroeconomic signals in performing its risk-separation processes; (ii) accordingly, Model 22's overall accuracy and propensity to increase loan approval rates was overstated; (iii) Model 22's overly conservative assessment of credit and macroeconomic conditions was having a significant negative impact on Upstart's revenue results, rendering Upstart's previously issued full year 2025 revenue guidance unreliable and/or unrealistic; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

If you are a UPST investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Medpace Holdings, Inc. (NASDAQ:MEDP)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made materially false and/or misleading statements and/or failed to disclose that: (i) Medpace's public statements regarding its expected book-to-bill ratio for the fourth quarter and second half of fiscal year 2025 lacked a reasonable basis; (ii) the Company repeatedly portrayed an overly optimistic book-to-bill ratio of approximately 1.15 during earnings calls and other public communications, despite contrary internal information; and (iii) as a result, the Company's statements about Medpace's business, operations, and financial prospects were materially false and misleading at all relevant times.

If you are an MEDP investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

Gossamer Bio, Inc. (NASDAQ:GOSS)

Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements and/or failed to disclose that: (i) while publicly touting overwhelmingly positive results to investors, the Company concealed material adverse facts regarding the design of the Company's Phase 3 PROSERA study, including their failure to adequately control for placebo response at the Latin American testing sites; and (ii) as a result of the foregoing, Gossamer's securities traded at artificially inflated prices.

If you are a GOSS investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

ATTORNEY ADVERTISING.© 2026 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516) 493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.

Lifshitz Law PLLC

Phone: 516-493-9780

Facsimile: 516-280-7376

Email: [email protected]

SOURCE: Lifshitz Law Firm